Press release
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summit in San Diego
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023 has been a monumental year for ADC discovery [https://www.creative-biolabs.com/adc/one-stop-adc-development-service.htm] in oncology, represented by the highly anticipated approval of the ninth ADC and a groundbreaking treatment for platinum-resistant ovarian cancer," a scientist at Creative Biolabs says, "and such achievements underscore the potential of ADCs to fight against many cancers beyond breast cancer, energizing the ADC community to push boundaries even further. The World ADC Summit offers an ideal platform for us to showcase how our services align with this momentum, propelling ADCs into frontline therapies that improve patient lives."
Creative Biolabs, particularly known for ADC discovery and development capabilities, supports every stage of ADC development from early discovery through clinical manufacturing, including antibody engineering, linker design, and payload selection.
A core strength lies in its bioconjugation chemistry services [https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm]-Creative Biolabs has mastered the art to offer expert antibody design and antibody-linker conjugations utilizing both site-specific and random conjugation methods, thus enabling the precise control over the attachment of cytotoxic drugs to antibodies and supporting clients in achieving the ideal balance between safety and efficacy for each therapeutic application.
"Designing a chemically compatible antibody for the conjugation chemistry is a key step intuitively dictating the fate of an ADC project. We've prepared engineered/non-engineered antibodies that are conjugated to the corresponding drug-linker set in DrugLnk, purified via suitable liquid chromatography techniques, and of course characterized for some basic biochemical parameters such as drug-to-antibody ratio, stability, and conjugation site distribution, to expedite your project with clear objectives." The scientist explains.
Further enhancing ADC functionality are specialized linker and payload solutions that Creative Biolabs tailors to fit the unique requirements of each ADC project. Linkers-responsible for releasing the drug payload [https://www.creative-biolabs.com/adc/drug-module.htm] only at the targeted cancer site-are available in cleavable and non-cleavable forms, providing flexibility based on therapeutic needs. The company's extensive catalog of payloads includes a range of cytotoxic agents, ensuring targeted destruction of cancer cells while minimizing side effects on healthy tissue.
Creative Biolabs extends a warm invitation to all World ADC attendees to visit Booth #313 to learn more about its ADC solutions and discuss potential collaborations. The Creative Biolabs team looks forward to meeting with industry experts, sharing insights, and advancing the conversation on ADCs' role in oncology and beyond.
Website: https://www.creative-biolabs.com/adc
About
The World ADC Summit is the beginning of a busy quarter for Creative Biolabs in 2024, which is set to appear at the Scientist Solution Vendor Event - NIH 37 and Antibody Engineering & Therapeutics (US) 2024 in December. These events present valuable opportunities to connect with global experts and forge partnerships that accelerate ADC breakthroughs.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=showing-off-their-adc-game-creative-biolabs-hits-the-15th-annual-world-adc-summit-in-san-diego]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/adc
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summit in San Diego here
News-ID: 3721785 • Views: …
More Releases from Getnews
CRUVHEAL Presents Five Insole Models Designed for Daily Performance
CRUVHEAL presents its core collection of insoles designed to meet the needs of workers, athletes, and anyone seeking comfort and stability in daily life. From reinforced arch designs to soft cushioning, every pair reflects the brand's commitment to practical foot health and everyday relief.
Image: https://www.globalnewslines.com/uploads/2025/10/a14d5a2a18ed367002a3e0e8b74d38d4.jpg
"Our goal has always been simple - to make people's days more comfortable," said a CRUVHEAL brand representative. "Whether it's a long shift on a factory…
The Hidden Story of Annie Turnbo Malone The First Black Female Millionaire by Ja …
Image: https://www.aionewswire.com/storage/images/ckeditor//Author%20Photo%20resized_1761233350.png
'The untold story of a beauty pioneer, philanthropist, and America's first Black female millionaire.'
Few names have been as overlooked in American history as Annie Turnbo Malone. Though she was the daughter of formerly enslaved parents and rose from the hardships of orphanhood and poverty, Annie became one of the first Black female millionaires in the United States. She built a global health and beauty empire, dedicated her fortune to…
Lionel Eba Innovative Approach Redefines Cultural Architecture in New York City
In the competitive landscape of New York hospitality, few figures have shaped cultural momentum as effectively as Lionel Eba. The entrepreneur and strategist, known for uniting creative forces and transforming ideas into lasting experiences, played a key role in the creation and early positioning of Sirrah, the Manhattan restaurant and lounge that has quickly become a magnet for tastemakers and trendsetters.
Image: https://www.globalnewslines.com/uploads/2025/10/31454a271b7743ca36910c927185ff4e.jpg
Long before opening night, Eba connected the venue's owners,…
Future Electronics Launches Quarterly Campaign Showcasing Next-Generation Health …
Image: https://www.globalnewslines.com/uploads/2025/10/1761211119.jpg
Future Electronics, a leading global distributor of electronic components, is excited to announce the launch of a new quarterly campaign focused on advancing the future of health and wellness.
Montreal, Canada - October 23, 2025 - Future Electronics, a leading global distributor of electronic components, is excited to announce the launch of a new quarterly campaign focused on advancing the future of health and wellness. Intelligent medical equipment and connected…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
ADC African Development Corporation GmbH & Co. KGaA: ADC exits shareholding in E …
ADC African Development Corporation (ADC), ISIN DE000A1E8NW9, a fast growing financial services group focusing on the frontier markets of sub-Saharan Africa, has successfully negotiated an exit for its 11.5% shareholding in Ecobank Zimbabwe for USD 5.2 million equaling approx. EUR 4.0 million. As of 30 September 2011, ADC had valued its shareholding in Ecobank Zimbabwe at EUR 1.25 million, so this transaction results in a realized profit of EUR 2.75…
